Pfizer to disclose payments to doctors
Wall Street Journal, February 10, 2009
Pfizer Inc. has announced that it will become the latest drug maker to publicly disclose the payments it makes to doctors. Pfizer will report all payments to doctors of more than $500 for consulting and speaking arrangements and will also make public the money it pays them to participate in its clinical trials. Federal legislation could soon mandate such transparency from the entire industry.
Most Viewed
Most Emailed
- $6.4B Henry Ford, Beaumont Merger Failed on Cultural Hurdles
- Don't Let Nurses Sink Your Bottom Line
- Hospitals Profit On Bloodstream Infections
- Fortunately, Angelina Jolie Isn't On Medicare
- Less Blood Testing for Some Surgeries Safe, Cost Effective
- Lower ED Margins Demand a Better Strategy
- How Chargemaster Data May Affect Hospital Revenue
- Primary Care Docs Average More Hospital Revenue Than Specialists
- House Lawmakers Grill CMS Over Health Exchange Navigators
- ED Physicians Key to Half of Hospital Admissions
